These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 1710656)

  • 1. Circulating Biomarkers for Therapeutic Monitoring of Anti-cancer Agents.
    Janse van Rensburg HJ; Spiliopoulou P; Siu LL
    Oncologist; 2022 May; 27(5):352-362. PubMed ID: 35285488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-overview.
    Omachi K
    Int J Hematol; 2019 Jul; 110(1):3-10. PubMed ID: 31152416
    [No Abstract]   [Full Text] [Related]  

  • 3. Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remission.
    Hawkes EA; Loh Z; Estacio O; Chong G; Ha FJ; Gilbertson M; Grigg A
    Br J Cancer; 2018 Aug; 119(5):546-550. PubMed ID: 30033446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance Scans in Lymphoma: Friend or Foe?
    Phillips T; Mercer J
    Curr Treat Options Oncol; 2017 Feb; 18(2):10. PubMed ID: 28214975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Tumor DNA to Monitor Therapy for Aggressive B-Cell Lymphomas.
    Kwok M; Wu SP; Mo C; Summers T; Roschewski M
    Curr Treat Options Oncol; 2016 Sep; 17(9):47. PubMed ID: 27461036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse Large B Cell Lymphoma with Extensive Cutaneous Relapse.
    Malkan UY; Gunes G; Yayar O; Demiroglu H
    Case Rep Med; 2015; 2015():137682. PubMed ID: 26457084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-generation surveillance strategies for patients with lymphoma.
    Cohen JB; Kurtz DM; Staton AD; Flowers CR
    Future Oncol; 2015; 11(13):1977-91. PubMed ID: 26161931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rethinking clinical response and outcome assessment in a biologic age.
    Cheson BD
    Curr Oncol Rep; 2015 Jun; 17(6):27. PubMed ID: 25975729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma.
    Thompson CA; Ghesquieres H; Maurer MJ; Cerhan JR; Biron P; Ansell SM; Chassagne-Clément C; Inwards DJ; Gargi T; Johnston PB; Nicolas-Virelizier E; Macon WR; Peix M; Micallef IN; Sebban C; Nowakowski GS; Porrata LF; Weiner GJ; Witzig TE; Habermann TM; Link BK
    J Clin Oncol; 2014 Nov; 32(31):3506-12. PubMed ID: 25267745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of relapsed-refractory diffuse large B cell lymphoma.
    Raut LS; Chakrabarti PP
    South Asian J Cancer; 2014 Jan; 3(1):66-70. PubMed ID: 24665451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of PET in lymphoma.
    Gallamini A; Borra A
    Curr Treat Options Oncol; 2014 Jun; 15(2):248-61. PubMed ID: 24619427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current role of FDG PET/CT in lymphoma.
    Kostakoglu L; Cheson BD
    Eur J Nucl Med Mol Imaging; 2014 May; 41(5):1004-27. PubMed ID: 24519556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of lactate dehydrogenase in the follow up of patients with diffuse large B-cell lymphoma.
    William BM; Bongu NR; Bast M; Bociek RG; Bierman PJ; Vose JM; Armitage JO
    Rev Bras Hematol Hemoter; 2013; 35(3):189-91. PubMed ID: 23904809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited role for surveillance PET-CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy.
    Cheah CY; Hofman MS; Dickinson M; Wirth A; Westerman D; Harrison SJ; Burbury K; Wolf M; Januszewicz H; Herbert K; Prince HM; Carney DA; Ritchie DS; Hicks RJ; Seymour JF
    Br J Cancer; 2013 Jul; 109(2):312-7. PubMed ID: 23807169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography/computed tomography surveillance in patients with lymphoma: a fox hunt?
    Gallamini A; Kostakoglu L
    Haematologica; 2012 Jun; 97(6):797-9. PubMed ID: 22665528
    [No Abstract]   [Full Text] [Related]  

  • 16. The evolving role of F-FDG PET scans in patients with aggressive non-Hodgkin's lymphoma.
    Hosein PJ; Lossos IS
    European J Clin Med Oncol; 2010 Feb; 2(1):131-138. PubMed ID: 22140415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of response to therapy using conventional imaging.
    Rankin SC
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S56-64. PubMed ID: 12664137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma.
    Even-Sapir E; Israel O
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S65-81. PubMed ID: 12644887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission.
    Weeks JC; Yeap BY; Canellos GP; Shipp MA
    J Clin Oncol; 1991 Jul; 9(7):1196-203. PubMed ID: 1710656
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.